SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid community discussion surrounding a recent shooting and its potential political motivations. The conversation includes speculation about the shooter's background and the broader implications for political rhetoric. Some are also discussing the company's financials and potential stock manipulation.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla ($TSLA) is trending amid discussions of a potential breakout, with bullish traders eyeing targets around $400 and beyond, while some warn of an overextended rally built on hype. Community members are actively debating the strength and sustainability of the stock's upward momentum, as well as its valuation relative to fundamentals. Recent comments from Tesla's chair regarding leadership plans and Elon Musk's focus are also fueling speculation.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending following regulatory approval from the UK for its acquisition of Oxford Ionics, which the company believes will accelerate its technology roadmap.  While some community members are excited about the deal and the potential for a "squeeze", others express skepticism about the long-term value and profitability of quantum computing companies. Some traders are focused on technical analysis, discussing potential breakouts and short-term trading opportunities.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending due to a mix of factors, including news of collaborations and positive trial results, though some reports about potential COVID vaccine risks are also circulating. Community discussion includes frustration with the stock's performance and speculation about potential catalysts, including buyouts or partnerships. The stock's movements are also being discussed in relation to broader market trends, potential government actions, and competitor activity in the pharmaceutical sector.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna's stock is trending downwards amid reports linking COVID-19 vaccines to child deaths and Trump administration scrutiny, sparking concerns about the company's future and government contracts. The community is actively discussing potential manipulation and corruption, while some view the dip as a buying opportunity or anticipate a short squeeze. Despite the negative news, some are optimistic about Moderna's pipeline beyond COVID-19 and its potential in AI-driven cancer treatments.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is seeing active discussion as the stock retraces after a significant run-up, with traders debating whether it's profit-taking or a deeper correction. The community is focused on potential support levels and the impact of a possible rate cut next week, while also reacting to the new CEO and board changes. Some traders express concerns about dilution and the CEO's compensation structure, while others remain bullish, citing long-term potential and upcoming catalysts.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid speculation of a potential takeover bid by Paramount Skydance, sparking significant trading volume and price movement. Community discussions revolve around potential bidding wars, valuation estimates, and the possibility of a deal announcement soon. Some investors are expressing concerns around debt and potential shareholder impact, while others are optimistic about a potential bidding war.

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

GCTK is trending due to recent news of a $20 million investment agreement, fueling speculation of a potential short squeeze given its low float; the community is actively discussing price targets and potential for significant upward movement. Anticipation is building around upcoming news and events, with some traders eyeing targets and suggesting a potential for a substantial rally. The stock is experiencing high volatility.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending as the quantum computing sector gains momentum, with community members discussing potential resistance levels and short positions.  Positive sentiment is fueled by news of collaborations and expansion, while some traders point to sector-wide movement possibly driven by speculative trading. Investors are weighing the company's growth potential against inherent risks in the quantum computing market.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending due to a significant multi-day rally, sparking community discussion about potential catalysts. Some speculate a possible buyout or major contract win is fueling the upwards movement, while others point to the company finally being recognized as a profitable AI pure-play. The community is also watching resistance levels closely and debating the potential for a short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates

Clearside Biomedical (CLSD) delivered earnings and revenue surprises of +50.00% and +87.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Compugen (CGEN) Reports Q2 Loss, Lags Revenue Estimates

Compugen (CGEN) delivered earnings and revenue surprises of -14.29% and -76.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know

Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates

Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates

Protagonist Therapeutics (PTGX) Reports Q1 Loss, Tops Revenue Estimates

Clearside Biomedical's CLS-AX Shows Promise in Phase 2b Trials, Yi Chen Maintains Buy Rating with $5 Price Target

Clearside Biomedical (CLSD Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yi Chen from H...

Buy Rating Affirmed for Clearside Biomedical on Promising Phase 3 Results and Innovative Drug Delivery System

H.C. Wainwright analyst Yi Chen has reiterated their bullish stance on CLSD stock, giving a Buy rating today. Yi Chen has given his Buy rating due...

Oppenheimer Sticks to Its Buy Rating for Clearside Biomedical (CLSD)

In a report released today, Andreas Argyrides from Oppenheimer maintained a Buy rating on Clearside Biomedical (CLSD Research Report), with a pri...

Buy Rating Affirmed: Clearside Biomedical's Innovative Drug Delivery and Promising Clinical Trials

Serge Belanger, an analyst from Needham, maintained the Buy rating on Clearside Biomedical (CLSD Research Report). The associated price target re...

Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases. Its pipeline includes CLS-AX, an Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.

Clearside Biomedical Inc

Buying for a long-term investment

Buying for a short-term trade

Trading around the volatility

Avoiding it

$GEMI IPO day is upon us, how are you playing it?

Stocktwits

Gemini Space Station

 IPO day is upon us, how are you playing it?

CLSD
Clearside Biomedical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CLSD News

CLSD Clearside Biomedical Inc